Papers/PMID:42152509
Clinical Outcomes of Selenium Supplementation in Hashimoto's Thyroiditis Without Selenium Deficiency: A Large-Scale Retrospective Cohort Study.
Endocrinology, diabetes & metabolism2026The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
selenium atom — increases all-cause mortality
Evidence strength: very limited.Finding“The incidence of all‐cause mortality was higher in the selenium‐treated group compared to the control group, with the difference reaching statistical significance (RR 1.63, 95% CI: 1.18–2.24) (Table 4).”
Quoted verbatim from Clinical Outcomes of Selenium Supplementation in Hashimoto's Thyroiditis Without Selenium Deficiency: A Large-Scale Retrospective Cohort Study.. - Study
- cohort
- Population
- Adults with Hashimoto thyroiditis and elevated thyroid autoantibodies in the TriNetX network; selenium supplementation within 6 months of diagnosis versus none, propensity-score matched
Effect 1.63 risk ratio, 95% CI 1.18 to 2.24
Clinical Outcomes of Selenium Supplementation in Hashimoto's Thyroiditis Without Selenium Deficiency: A Large-Scale Retrospective Cohort Study.2026PMID:4215250910.1002/edm2.70239Permalink